Subscribe

Cannabis ETFs face a ‘day of reckoning’

The funds have returned more than 30% so far this year, but will investor enthusiasm wane?

There may be trouble ahead for the growing number of exchange-traded funds that invest in cannabis companies.

Pot ETFs face a "day of reckoning" within the next couple of years as investor interest in the industry — which has returned more than 30% in 2019 — begins to fade, according to Daniel

Subscribe or log in to read the rest of this content.

Related Topics: ,

Learn more about reprints and licensing for this article.

Recent Articles by Author

Bank of America sounds warning on options-ETF boom

Skeptics says products often fare worse than simpler alternatives.

Gold in flux as investors await Fed meeting

Following a 13 percent advance this year, the price of the yellow metal wavered as traders weigh the odds of harmful rate hikes.

Hedge funds ramp up tech allocations, says Goldman

Data show amped-up net buying in sector through long positions and short-covering even amid a slide in S&P 500 IT index.

Stocks rise following hot March inflation

The S&P 500 is poised to extend gains on tech earnings while short-term Treasury yields fell following brisk rise in Fed’s preferred inflation gauge.

Fed will cut once before presidential election, says Howard Lutnick

Cantor Fitzgerald’s chief executive predicts the central bank will “show off a little bit” just before voters head to the polls.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print